Enfortumab vedotin-induced bullous dermatitis
Dermatology Online Journal · 2025
DOI: 10.5070/d331365370 ↗Kurz gefasst
Fallbericht in der Zeitschrift Dermatology Online Journal, 2025. Verfasst von Robin Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Loyola University Medical Center, Maywood, Illinois, United States. Robin.wang@luhs.org. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Drug Eruptions, Skin Diseases, Vesiculobullous, Immunoconjugates. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Loyola University Medical Center, Maywood, Illinois, United States. Robin.wang@luhs.org.
Zitieren
APA
Wang, R., Fernandez, K., Zelman, B., Speiser, J., Dahiya, M., & Eilers, D. (2025). Enfortumab vedotin-induced bullous dermatitis. Dermatology Online Journal. https://doi.org/10.5070/d331365370
Vancouver
Wang R, Fernandez K, Zelman B, Speiser J, Dahiya M, Eilers D. Enfortumab vedotin-induced bullous dermatitis. Dermatology Online Journal. 2025. doi:10.5070/d331365370
BibTeX
@article{Wang2025,
author = {Wang, Robin and Fernandez, Kristen and Zelman, Brandon and Speiser, Jodi and Dahiya, Madhu and Eilers, David},
title = {Enfortumab vedotin-induced bullous dermatitis},
journal = {Dermatology Online Journal},
year = {2025},
doi = {10.5070/d331365370}
}
EUVIMED